SOURCE: Reliv International, Inc.

Reliv International: The Nutritional Epigenetics Company

December 11, 2015 07:00 ET

Reliv International, Inc. Announces $500,000 Stock Repurchase Program

CHESTERFIELD, MO--(Marketwired - December 11, 2015) - Reliv International, Inc. (NASDAQ: RELV) announced today that its Board of Directors has authorized a stock repurchase program of up to $500,000 of the company's outstanding common stock.

The stock repurchase program is expected to be completed over the next 24 months.

The shares may be repurchased from time to time in open market transactions at prevailing market prices or by other means in accordance with federal securities laws. The actual timing, number and value of shares repurchased under the program will be determined by management at its discretion and will depend on a number of factors, including the market price of the Company's stock, general market and economic conditions and applicable legal requirements.

Robert L. Montgomery, Chief Executive Officer, stated: "We believe that, at current market levels, the stock of our Company is a good investment and an appropriate use of our corporate funds.

About Reliv International, Inc.

Reliv International, based in Chesterfield, MO, produces nutritional supplements that promote optimal nutrition. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, a soy peptide that works at the epigenetic level to promote optimal health. The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at reliv.com, or on Facebook, Twitter or YouTube.

Statements made in this news release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv's business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company's web site, reliv.com.

Contact Information

  • For more information, contact:
    Steve Albright
    Chief Financial Officer
    (636) 733-1305